Skip to content
Khush Aujla, M.D.

Khush Aujla, M.D.

Radiation Oncology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 341-6750
Administrative (585) 341-6750

About Me

Throughout my medical training, I have been fascinated with the cross section of technology and healthcare. Radiation Oncology is an ever evolving field that provides an opportunity to utilize both physics and biology to help patients with cancer. My goal is to give my patients the best care possibl...
Throughout my medical training, I have been fascinated with the cross section of technology and healthcare. Radiation Oncology is an ever evolving field that provides an opportunity to utilize both physics and biology to help patients with cancer. My goal is to give my patients the best care possible by learning and applying the continuous advancements occurring in cancer treatment. I strive to provide the best understanding of evidence based medicine for any situation, while emphasizing shared decision making with the patient and family.

My areas of interest include the utilization of brachytherapy for gynecologic cancers, genitourinary cancers, as well as skin cancers. I also maintain a general radiation oncology practice and feel comfortable treating all other disease sites. On a personal note – my name Khush means “happy” in my native language. I aim to embody my name by maintaining a positive and optimistic attitude with colleagues and patients, while staying respectful and prepared for the challenges of cancer.

Professional Background

University of Rochester Medical Center: 2021 Residency, Radiation Oncology

University of Mississippi Medical Center: 2017 Internship, Medicine

University of Mississippi Medical Center: 2016 MD

University of Mississippi: 2012 BA


Clinical Experience
• IMRT, VMAT, I...
University of Rochester Medical Center: 2021 Residency, Radiation Oncology

University of Mississippi Medical Center: 2017 Internship, Medicine

University of Mississippi Medical Center: 2016 MD

University of Mississippi: 2012 BA


Clinical Experience
• IMRT, VMAT, IGRT through Varian, TomoTherapy, and Elekta machines
• SBRT though Varian and BrainLab Systems
• SRS/SRT, frameless and framed with BrainLab and Varian systems
• Inspiration and Expiration breath hold with infra-red and patient feedback
• SpaceOAR, HDR and LDR brachytherapy for Prostate cancer
• HDR brachytherapy for gynecologic sites
• Y-90 microspheres
• Aria and Mosaiq record and verify systems
• Eclipse and Pinnacle contour and planning systems

Credentials

Residency & Fellowship

Residency, Radiation Oncology, University of Rochester Medical Center. 2017 - 2021

Internship, Internal Medicine, University of Mississippi Medical Center. 2016 - 2017

Education

MD | University Of Mississippi Medical Center (USA). 2016

Awards

Strong Star Certification of Faculty Appreciation. 2019

ASTRO Annual Conference – Mini-Oral Scientific Session Presenter. 2018

Strong Star Certification of Patient Appreciation. 2017

Alpha Omega Alpha (AOA) Inductee. 2016

Medical Student Research Scholar, Graduation Distinction. 2016

American College of Rheumatology Research Travel Award. 2014

Summa Cum Laude – University of Mississippi. 2012

McDonnell-Barksdale Honors College full academic scholarship. 2008 - 2012

Publications

Journal Articles

Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.

Milano MT, Katz AW, Zhang H, Huggins CF, Aujla KS, Okunieff P

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2019 February 131 :45-51. Epub 12/28/2018.

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years.

Aujla KS, Katz AW, Singh DP, Okunieff P, Milano MT

Frontiers in oncology.. 2019 9 :111. Epub 02/27/2019.

Assessment of Secondary Causes of Osteoporosis and Racial Differences in Men with Normal vs. Abnormal Bone Mineral Density in a Cohort of Men Undergoing Bone Mass Measurement.

Aujla K, Majithia V

Journal of the Mississippi State Medical Association. 2016 September 57 (9):285-288. Epub 1900 01 01.

Extreme hypercalcemia leading to the diagnosis of extensive sarcoidosis.

Aujla K, Majithia V, Green A

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.. 2014 September 20 (6):328-9. Epub 1900 01 01.